Media Centre
Latest press releases
-
Perioperative Imfinzi plus neoadjuvant enfortumab vedotin granted Priority Review in the US for patients with muscle-invasive bladder cancer
-
Alexion advances pioneering leadership in gMG care with data at 2026 AANEM Annual Meeting and MGFA Scientific Session
-
AstraZeneca expands company’s $100m+ commitment to advance youth health equity in more than 60 countries
-
Trixeo approved in the EU for the maintenance treatment of asthma
-
Klygefa (gefurulimab) recommended for approval in the EU by CHMP for the treatment of adults with generalised myasthenia gravis (gMG)
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
